DataMeds AI Inc. (MEDS)
NASDAQ
Closed
Sep 18, 2026
Day's Range
3.4552 wk Range
0.8230Overview - MEDS - DataMeds AI Inc.
Key Statistics
Valuation
Enterprise Value
32.92M
P/E (Trailing)
‪-0.02‬
P/E (Forward)
‪-16.86‬
PEG Ratio
‪-0.00084‬
Price / Sales (TTM)
‪0.33‬
Price / Book
‪-0.23‬
EV / EBITDA
‪-0.59‬
Profitability
Gross Margin
‪10.23%‬
Profit Margin
‪-27.53%‬
Operating Margin
‪-412.67%‬
Return on Assets
‪-82.92%‬
Return on Equity
‪813.59%‬
Ownership
Shares Outstanding
2.83M
Float
1.48M
Short % of Shares Outstanding
‪8.64%‬
Held by Insiders
‪56.12%‬
Held by Institutions
‪1.70%‬
Price stats
50-Day Avg
‪2.14‬
200-Day Avg
‪9.67‬
Dividends
Payout Ratio
‪0.00%‬
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - MEDS - DataMeds AI Inc.
Peers - MEDS - DataMeds AI Inc.
Peer Comparison
Compared with companies in Medical Distribution listed on NASDAQ.
Profile Summary - MEDS - DataMeds AI Inc.
About
DataMeds AI Inc. is a healthcare technology and pharmaceutical logistics company that focuses on integrating pharmacy operations, digital health infrastructure, and health information tools. The company provides technology-driven solutions that support prescription fulfillment, pharmacy coordination, clinical…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
